WifeampMum Posted September 6, 2016 Posted September 6, 2016 Morning,A query for PCUK:Is there any update regarding the CDF's 2015 delisting of Abraxane for patients in England. I believe that NICE is meant to be reviewing this disgraceful situation?ThanksW&M
PCUK Nurse Jeni Posted September 6, 2016 Posted September 6, 2016 Hello W&M,Thanks for your query.Pancreatic Cancer UK are aware that this is on the agenda for NICE to be re-appraised however we have not been given a date at this point in time. We will update once we have some confirmation from NICE.Kind regards,Jeni.Jeni JonesPancreatic Cancer Specialist NurseSupport TeamPancreatic Cancer UKemail: support@pancreaticcancer.org.uksupport line: 0808 801 0707
WifeampMum Posted September 6, 2016 Author Posted September 6, 2016 Many thanks Jeni, I hope we hear soon and that it's something to celebrate. I've seen numerous U.S. articles recently that refer to Abraxane (with Gemcitabine) as being/becoming the standard of care. It's so galling that it's only available in England to private patients and those on trials. Best wishesW&M
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now